Skip to main content

Jason Gerberry

Stock Analyst at Bank of America Securities

Total Price Targets
11
Stocks Covered
10
Sectors
Healthcare
Most Recent
Oct 15, 2024

Stocks Covered by Jason Gerberry

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
BHVNBiohaven Ltd.$65.00$9.71+569.4%2Oct 15, 2024
PROKProKidney Corp.$3.00$1.94+55.0%1Sep 4, 2024
EXELExelixis, Inc.$30.00$43.81-31.5%1Sep 4, 2024
RLAYRelay Therapeutics, Inc.$20.00$12.90+55.0%1Sep 4, 2024
PCVXVaxcyte, Inc.$140.00$57.52+143.4%1Sep 4, 2024
LQDALiquidia Corporation$23.00$38.21-39.8%1Aug 20, 2024
AXSMAxsome Therapeutics, Inc.$106.00$204.09-48.1%1Aug 6, 2024
IONSIonis Pharmaceuticals, Inc.$30.00$75.86-60.5%1Feb 1, 2022
JAZZJazz Pharmaceuticals plc$193.00$202.38-4.6%1Nov 10, 2021
ALLOAllogene Therapeutics, Inc.$32.00$2.15+1391.8%1Oct 8, 2021

Recent Activity

  • Oct 15, 2024— Set$65.00price target onBHVN(Biohaven Ltd.)
  • Sep 24, 2024— Set$62.00price target onBHVN(Biohaven Ltd.)
  • Sep 4, 2024— Set$140.00price target onPCVX(Vaxcyte, Inc.)
  • Sep 4, 2024— Set$20.00price target onRLAY(Relay Therapeutics, Inc.)
  • Sep 4, 2024— Set$3.00price target onPROK(ProKidney Corp.)
  • Sep 4, 2024— Set$30.00price target onEXEL(Exelixis, Inc.)
  • Aug 20, 2024— Set$23.00price target onLQDA(Liquidia Corporation)
  • Aug 6, 2024— Set$106.00price target onAXSM(Axsome Therapeutics, Inc.)
  • Feb 1, 2022— Set$30.00price target onIONS(Ionis Pharmaceuticals, Inc.)
  • Nov 10, 2021— Set$193.00price target onJAZZ(Jazz Pharmaceuticals plc)
  • Oct 8, 2021— Set$32.00price target onALLO(Allogene Therapeutics, Inc.)

Frequently Asked Questions

Who is Jason Gerberry?

Jason Gerberry is a stock analyst at Bank of America Securities covering 10 stocks primarily in Healthcare. They have issued 11 price targets since Oct 8, 2021.

What stocks does Jason Gerberry cover?

Jason Gerberry currently covers 10 stocks, including BHVN, PROK, EXEL, RLAY, PCVX.

What is Jason Gerberry's latest price target?

Jason Gerberry's most recent price target was $65.00 on BHVN (Biohaven Ltd.), set on Oct 15, 2024.

What is Jason Gerberry's highest price target?

Jason Gerberry's highest issued price target is $193.00 on JAZZ, set on Nov 10, 2021.

Coverage based on publicly published price targets. Not investment advice.